Orient EuroPharma Co., Ltd. (TPEX: 4120)
Taiwan
· Delayed Price · Currency is TWD 48.40
-0.75 (-1.53%)
Nov 18, 2024, 1:30 PM CST
Orient EuroPharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 190.91 | 143.94 | -310.8 | 120.17 | 199.3 | 247.66 | Upgrade
|
| Depreciation & Amortization | 211.01 | 216.26 | 194.31 | 191.09 | 196.82 | 182.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -229.47 | -234.5 | -72.35 | -182.38 | -1.07 | -1.51 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 35.3 | 10 | - | 23.15 | Upgrade
|
| Loss (Gain) on Equity Investments | 19.25 | 18.27 | 30.14 | 19.14 | 16.88 | 8.13 | Upgrade
|
| Provision & Write-off of Bad Debts | 14.06 | 1.53 | -0.4 | -2.46 | -0.36 | -5.35 | Upgrade
|
| Other Operating Activities | 75.73 | 133.31 | 110.33 | -22.62 | -15.78 | 31.31 | Upgrade
|
| Change in Accounts Receivable | -79.39 | -14.93 | -112.85 | -60.86 | 139.66 | 34.96 | Upgrade
|
| Change in Inventory | 89.44 | 128.64 | -391.29 | 210.37 | 48.57 | -404.77 | Upgrade
|
| Change in Accounts Payable | -241.84 | -202.1 | 392.98 | -158.56 | -15.56 | 34.86 | Upgrade
|
| Change in Other Net Operating Assets | -7.39 | -69.44 | -94.12 | -46.25 | 40.08 | 76.63 | Upgrade
|
| Operating Cash Flow | 42.32 | 120.98 | -218.75 | 77.65 | 608.55 | 227.37 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -87.24% | 167.65% | -1.70% | Upgrade
|
| Capital Expenditures | -67.94 | -99.4 | -639.16 | -1,563 | -232.78 | -124.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 424.98 | 424.44 | 101.91 | 216.12 | 1.12 | 1.77 | Upgrade
|
| Sale (Purchase) of Intangibles | 0.35 | -1.3 | -1.93 | -5.05 | -2.33 | -53.71 | Upgrade
|
| Investment in Securities | -343.92 | -251.13 | -84.86 | -136.58 | -122.57 | 2.16 | Upgrade
|
| Other Investing Activities | 6.82 | -10.51 | 12.48 | -6.95 | 8.6 | -10.94 | Upgrade
|
| Investing Cash Flow | 20.28 | 62.11 | -611.56 | -1,495 | -367.59 | -199.95 | Upgrade
|
| Short-Term Debt Issued | - | 132.65 | 141.16 | 825.54 | 29.55 | 545.03 | Upgrade
|
| Long-Term Debt Issued | - | 154.15 | 701.57 | 1,251 | 396 | 68 | Upgrade
|
| Total Debt Issued | 438.47 | 286.79 | 842.72 | 2,076 | 425.55 | 613.03 | Upgrade
|
| Long-Term Debt Repaid | - | -481.06 | -322.9 | -275.5 | -225.47 | -177.42 | Upgrade
|
| Total Debt Repaid | -722.24 | -481.06 | -322.9 | -275.5 | -225.47 | -177.42 | Upgrade
|
| Net Debt Issued (Repaid) | -283.77 | -194.27 | 519.82 | 1,801 | 200.08 | 435.61 | Upgrade
|
| Common Dividends Paid | -86.75 | - | -73.74 | -130.12 | -156.15 | -156.15 | Upgrade
|
| Other Financing Activities | -45.59 | -15.44 | -17.78 | -311.13 | 178.58 | -216.26 | Upgrade
|
| Financing Cash Flow | -416.11 | -209.71 | 428.31 | 1,360 | 222.51 | 63.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | -46.61 | -38.28 | 243.72 | -104.14 | -94.25 | -89.34 | Upgrade
|
| Net Cash Flow | -400.12 | -64.91 | -158.28 | -162.09 | 369.22 | 1.29 | Upgrade
|
| Free Cash Flow | -25.63 | 21.58 | -857.91 | -1,485 | 375.77 | 102.39 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 266.99% | 244.70% | Upgrade
|
| Free Cash Flow Margin | -0.57% | 0.47% | -18.14% | -31.15% | 6.98% | 1.68% | Upgrade
|
| Free Cash Flow Per Share | -0.30 | 0.25 | -9.89 | -17.08 | 4.31 | 1.18 | Upgrade
|
| Cash Interest Paid | 27.24 | 104.9 | 66.9 | 37.17 | 30.24 | 24.9 | Upgrade
|
| Cash Income Tax Paid | - | 21.75 | 21.75 | 60.83 | 120.51 | 103.42 | Upgrade
|
| Levered Free Cash Flow | 83.32 | 147.34 | -713.27 | -1,456 | 290.92 | -15.11 | Upgrade
|
| Unlevered Free Cash Flow | 150.96 | 213.65 | -669.81 | -1,432 | 309.81 | 0.46 | Upgrade
|
| Change in Net Working Capital | 58.82 | -53.96 | 129.57 | -4.65 | -272.79 | 218.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.